{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:32:23Z","timestamp":1791307943118,"version":"4.3.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.ijpharm.2007.06.016","type":"journal-article","created":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T07:19:19Z","timestamp":1182323959000},"page":"93-101","source":"Crossref","is-referenced-by-count":204,"title":["Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations"],"prefix":"10.1016","volume":"347","author":[{"given":"Tushar K.","family":"Vyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliasgar","family":"Shahiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor M.","family":"Amiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2007.06.016_bib1","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2527\/2005.8392175x","article-title":"Supplemental safflower oil affects the fatty acid profile, including conjugated linoleic acid, of lamb","volume":"83","author":"Boles","year":"2005","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF02825828","article-title":"New antiretroviral drugs in clinical use","volume":"73","author":"Chearskul","year":"2006","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/77481","article-title":"Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy","volume":"6","author":"Chun","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib4","first-page":"15","article-title":"HIV compartmentalization: pathogenesis and clinical implications","volume":"2","author":"Clarke","year":"2000","journal-title":"AIDS Rev."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1385\/JMN:16:2-3:181","article-title":"Esssential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport","volume":"16","author":"Edmond","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00003495-200060020-00016","article-title":"Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection","volume":"60","author":"Figgitt","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2007.06.016_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1600-0714.2005.00337.x","article-title":"Current trends of HIV disease of the mouth","volume":"34","author":"Frezzini","year":"2005","journal-title":"J. Oral. Pathol. Med."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1742-4690-3-72","article-title":"A reflection on HIV\/AIDS research after 25 years","volume":"3","author":"Gallo","year":"2006","journal-title":"Retrovirology"},{"key":"10.1016\/j.ijpharm.2007.06.016_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/dmd.105.007088","article-title":"Demonstration of docosahexanoic acid as a bioavailability enhancer for CYP3A substrates: In vitro and In vivo evidence using cyclosporine in rats","volume":"34","author":"Hirunpanich","year":"2005","journal-title":"Drug Metab. Disp."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1258\/095646205774988109","article-title":"Causes of the decline in AIDS deaths, United States, 1995\u20132002: prevention, treatment or both?","volume":"16","author":"Holtgrave","year":"2005","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.ijpharm.2007.06.016_bib11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1124\/mol.59.4.806","article-title":"P-glycoprotein limits oral availability, brain, and fetal penetration of Saquinavir even with high doses of ritonavir","volume":"59","author":"Huisman","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/10942910600596464","article-title":"Nano-Emulsion production by sonication and microfluidization\u2014a comparison","volume":"9","author":"Jafari","year":"2006","journal-title":"Int. J. Food Properties"},{"key":"10.1016\/j.ijpharm.2007.06.016_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1750-3639.2003.tb00011.x","article-title":"Assessing the efficacy of highly active antiretroviral therapy in the brain","volume":"13","author":"Kandanearatchi","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00075197-200203000-00003","article-title":"Long-chain polyunsaturated fatty acid accretion in brain","volume":"5","author":"Kemin","year":"2002","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ijpharm.2007.06.016_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00003088-200443050-00003","article-title":"Pharmacokinetic enhancement of protease inhibitor therapy","volume":"43","author":"King","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/157016206776055084","article-title":"HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability, and potential strategies for eradication","volume":"4","author":"Kulkovsky","year":"2006","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0006-2952(99)00377-9","article-title":"Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats","volume":"59","author":"Lo","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1088\/0957-0233\/17\/2\/009","article-title":"A comparative study of ultrasound and laser light diffraction techniques for particle size determination in dairy beverages","volume":"17","author":"Meyer","year":"2006","journal-title":"Meas. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib19","first-page":"17","article-title":"Intestinal lmphatic targeting of drugs","volume":"13","author":"O\u2019Driscoll","year":"2003","journal-title":"S.T.P. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib20","first-page":"769","article-title":"Anti-HIV drugs and drug delivery system","volume":"56","author":"Obaru","year":"1998","journal-title":"Nippon Rinsho."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.280.1.67","article-title":"Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy","volume":"280","author":"Schrager","year":"1998","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib22","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1007\/s11095-006-9101-7","article-title":"Intracellular delivery of Saquinavir in biodegradable polymeric nanoparticles for HIV\/AIDS","volume":"23","author":"Shah","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/108729101753205676","article-title":"Reservoirs for HIV infection and their persistence in the face of undetectable viral load","volume":"15","author":"Sonza","year":"2001","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.ijpharm.2007.06.016_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1211\/0022357055173","article-title":"Transport of prostaglandin E1 across the blood\u2013brain barrier in rats","volume":"57","author":"Taogoshi","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib25","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1166\/jnn.2006.440","article-title":"Improved oral delivery of paclitaxel following administration in nanoemulsion formulations","volume":"6","author":"Tiwari","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/17425247.3.5.613","article-title":"Nanoparticulate drug carriers for delivery of HIV\/AIDS therapy to viral reservoir sites","volume":"3","author":"Vyas","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2007.06.016_bib27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000200498","article-title":"Comparison of bile salt perturbation of duodenal and jejunal isolated brush-border membranes","volume":"47","author":"Zhao","year":"1990","journal-title":"Digestion"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517307005169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517307005169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T01:37:07Z","timestamp":1556501827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517307005169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0378517307005169"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2007.06.016","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}